Ingredients per Serving (2 capsules): BPC-157 Arginine 500mcg Osthole 98% 150mg 5a-hydroxy Laxogenin 25mg PEA with Levagen 300mg In a synergistic approach to research, the combination of BPC-157 Arginine, Osthole 98%, 5a-hydroxy Laxogenin, and PEA with Levagen offers a multifaceted exploration of potential therapeutic properties
Typical treatment protocols: Cycles of 5 days per week for 1-3 months, followed by 2-4 weeks off
Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban
This will decrease the deposit of fat, and speed up the removal of fat in the body
It should contain a lyophilized (freeze-dried) powder
(2018, PMID 30063858) reviewed animal stroke studies and found that thymosin beta-4 aided recovery after brain injuries